Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

OBJECTIVE: Evaluate intravitreal 0.5 mg ranibizumab or 4 mg triamcinolone combined with focal/grid laser compared with focal/grid laser alone for treatment of diabetic macular edema (DME). DESIGN: Multicenter, randomized clinical trial. PARTICIPANTS: A total of 854 study eyes of 691 participants wit...

Full description

Saved in:
Bibliographic Details
Main Authors: Elman, Michael J., Aiello, Lloyd Paul, Beck, Roy W., Bressler, Neil M., Bressler, Susan B., Edwards, Allison R., Ferris, Frederick L., Friedman, Scott M., Glassman, Adam R., Miller, Kellee M., Scott, Ingrid U., Stockdale, Cynthia R., Sun, Jennifer K.
Format: Artigo
Language:Inglês
Published: 2010
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2937272/
https://ncbi.nlm.nih.gov/pubmed/20427088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2010.02.031
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items